Promising Alzheimer’s drug may also improve memory in Down syndrome and normal aging
New research is breaking ground in repurposing an FDA-approved drug as a potential treatment in Down syndrome and normal aging. The results suggest that GM-CSF
March 29, 2022
No Comments